This is a Validated Antibody Database (VAD) review about
human TRAIL, based on 16 published articles (
read how Labome selects the articles), using TRAIL antibody in all methods. It is aimed to help Labome visitors find the most suited TRAIL antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
TRAIL synonym: APO2L; Apo-2L; CD253; TL2; TNLG6A; TRAIL
BioLegend
| mouse monoclonal (RIK-2) | - immunocytochemistry; human; 1:50; loading ...; fig 4d
| BioLegend TRAIL antibody (BioLegend, RIK2) was used in immunocytochemistry on human samples at 1:50 (fig 4d). Nat Commun (2017) ncbi |
| mouse monoclonal (RIK-2) | - flow cytometry; human; loading ...; fig 4c
| BioLegend TRAIL antibody (Biolegend, 308210) was used in flow cytometry on human samples (fig 4c). Cell (2016) ncbi |
| mouse monoclonal (RIK-2) | - blocking or activating experiments; human; fig 4
| BioLegend TRAIL antibody (biolegend, RIK-2) was used in blocking or activating experiments on human samples (fig 4). Leuk Res (2015) ncbi |
R&D Systems
| mouse monoclonal (75402) | - immunohistochemistry - paraffin section; human
| R&D Systems TRAIL antibody (R&D Systems, MAB687) was used in immunohistochemistry - paraffin section on human samples . Clin Breast Cancer (2015) ncbi |
Invitrogen
| mouse monoclonal (RIK-2) | | Invitrogen TRAIL antibody (eBioscience, RIK-2) was used in flow cytometry on human samples . Eur J Immunol (2015) ncbi |
Abcam
| domestic rabbit polyclonal | - western blot; human; loading ...; fig 4l
| Abcam TRAIL antibody (Abcam, ab9959) was used in western blot on human samples (fig 4l). Sci Adv (2021) ncbi |
Novus Biologicals
| mouse monoclonal (55B709.3) | - western blot; human; 1:1000; loading ...; fig 10b
| Novus Biologicals TRAIL antibody (Novus Bio, 55B709.3) was used in western blot on human samples at 1:1000 (fig 10b). Mol Cell Biol (2017) ncbi |
Cell Signaling Technology
| domestic rabbit monoclonal (C92B9) | - western blot; human; fig 1j
| Cell Signaling Technology TRAIL antibody (Cell Signaling Technology, C92B9) was used in western blot on human samples (fig 1j). elife (2021) ncbi |
| domestic rabbit monoclonal (C92B9) | - western blot; human; 1:1000; loading ...; fig 5b
| Cell Signaling Technology TRAIL antibody (Cell Signaling Technology, 3219) was used in western blot on human samples at 1:1000 (fig 5b). Front Neurosci (2019) ncbi |
| domestic rabbit monoclonal (C92B9) | - immunoprecipitation; human; loading ...; fig 1e
| Cell Signaling Technology TRAIL antibody (Cell Signaling, C92B9) was used in immunoprecipitation on human samples (fig 1e). Oncogene (2017) ncbi |
| domestic rabbit monoclonal (C92B9) | - flow cytometry; human; loading ...; fig 4c
| Cell Signaling Technology TRAIL antibody (Cell Signaling, 3219S) was used in flow cytometry on human samples (fig 4c). Invest New Drugs (2015) ncbi |
BD Biosciences
| mouse monoclonal (RIK-2) | - flow cytometry; human; loading ...; fig 2b
| BD Biosciences TRAIL antibody (BD Biosciences, RIK-2) was used in flow cytometry on human samples (fig 2b). Sci Rep (2017) ncbi |
| mouse monoclonal (RIK-2) | - flow cytometry; human; fig st1
| In order to find cell-surface markers specific to human neutrophils, BD Biosciences TRAIL antibody (BD, 550516) was used in flow cytometry on human samples (fig st1). Exp Cell Res (2016) ncbi |
| mouse monoclonal (RIK-2) | - flow cytometry; human; fig 7
| BD Biosciences TRAIL antibody (BD Biosciences, 550516) was used in flow cytometry on human samples (fig 7). Retrovirology (2015) ncbi |
| mouse monoclonal (B35-1) | | BD Biosciences TRAIL antibody (BD Biosciences, 556468) was used in western blot on human samples . Carcinogenesis (2009) ncbi |
Developmental Studies Hybridoma Bank
| mouse monoclonal (AFFN-TNFSF10-11F2) | - western blot; human; 1:1000; loading ...; fig 3b
| Developmental Studies Hybridoma Bank TRAIL antibody (DSHB, AFFN-TNFSF10-11F2) was used in western blot on human samples at 1:1000 (fig 3b). J Clin Med (2020) ncbi |
Jeong D, Kim H, Kim H, Kang M, Jung H, Oh Y,
et al. Soluble Fas ligand drives autoantibody-induced arthritis by binding to DR5/TRAIL-R2. elife. 2021;10:
pubmed publisher Kitamura Y, Kanaya N, Moleirinho S, Du W, Reinshagen C, Attia N,
et al. Anti-EGFR VHH-armed death receptor ligand-engineered allogeneic stem cells have therapeutic efficacy in diverse brain metastatic breast cancers. Sci Adv. 2021;7:
pubmed publisher Viana G, Priestman D, Platt F, Khan S, Tomatsu S, Pshezhetsky A. Brain Pathology in Mucopolysaccharidoses (MPS) Patients with Neurological Forms. J Clin Med. 2020;9:
pubmed publisher Dong H, Ye X, Zhong L, Xu J, Qiu J, Wang J,
et al. Role of FOXO3 Activated by HIV-1 Tat in HIV-Associated Neurocognitive Disorder Neuronal Apoptosis. Front Neurosci. 2019;13:44
pubmed publisher Allan D, Cerdeira A, Ranjan A, Kirkham C, Aguilar O, Tanaka M,
et al. Transcriptome analysis reveals similarities between human blood CD3- CD56bright cells and mouse CD127+ innate lymphoid cells. Sci Rep. 2017;7:3501
pubmed publisher Iurlaro R, Püschel F, León Annicchiarico C, O Connor H, Martin S, Palou Gramón D,
et al. Glucose Deprivation Induces ATF4-Mediated Apoptosis through TRAIL Death Receptors. Mol Cell Biol. 2017;37:
pubmed publisher Smith N, Pietrancosta N, Davidson S, Dutrieux J, Chauveau L, Cutolo P,
et al. Natural amines inhibit activation of human plasmacytoid dendritic cells through CXCR4 engagement. Nat Commun. 2017;8:14253
pubmed publisher Roybal K, Williams J, Morsut L, Rupp L, Kolinko I, Choe J,
et al. Engineering T Cells with Customized Therapeutic Response Programs Using Synthetic Notch Receptors. Cell. 2016;167:419-432.e16
pubmed publisher Li Z, Bridges B, Olson J, Weinman S. The interaction between acetylation and serine-574 phosphorylation regulates the apoptotic function of FOXO3. Oncogene. 2017;36:1887-1898
pubmed publisher Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9
pubmed publisher Heigele A, Joas S, Regensburger K, Kirchhoff F. Increased susceptibility of CD4+ T cells from elderly individuals to HIV-1 infection and apoptosis is associated with reduced CD4 and enhanced CXCR4 and FAS surface expression levels. Retrovirology. 2015;12:86
pubmed publisher Difranco K, Johnson Farley N, Bertino J, Elson D, Vega B, Belinka B,
et al. LFA-1-targeting Leukotoxin (LtxA; Leukothera®) causes lymphoma tumor regression in a humanized mouse model and requires caspase-8 and Fas to kill malignant lymphocytes. Leuk Res. 2015;39:649-56
pubmed publisher Guzmán E, Maers K, Roberts J, Kemami Wangun H, Harmody D, Wright A. The marine natural product microsclerodermin A is a novel inhibitor of the nuclear factor kappa B and induces apoptosis in pancreatic cancer cells. Invest New Drugs. 2015;33:86-94
pubmed publisher Ziblat A, Domaica C, Spallanzani R, Iraolagoitia X, Rossi L, Avila D,
et al. IL-27 stimulates human NK-cell effector functions and primes NK cells for IL-18 responsiveness. Eur J Immunol. 2015;45:192-202
pubmed publisher Labovsky V, Martinez L, Davies K, Garcia Rivello H, Calcagno M, Matas A,
et al. Association between ligands and receptors related to the progression of early breast cancer in tumor epithelial and stromal cells. Clin Breast Cancer. 2015;15:e13-21
pubmed publisher Luce A, Courtin A, Levalois C, Altmeyer Morel S, Romeo P, Chevillard S,
et al. Death receptor pathways mediate targeted and non-targeted effects of ionizing radiations in breast cancer cells. Carcinogenesis. 2009;30:432-9
pubmed publisher
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.
